Abstract
Oxidative stress plays a crucial role in the pathogenesis of peripheral artery disease (PAD). This study aimed to investigate the effect of clopidogrel on oxidative stress in PAD patients. Seventy subjects were divided into three groups: PAD patients before treatment (B-PAD), PAD patients after treatment with clopidogrel (A-PAD), and healthy controls. Serum levels of superoxide dismutase (SOD), copper (Cu), zinc (Zn), manganese (Mn), and oxidized protein were measured. SOD activities were also determined. The results showed that SOD activities, and SOD specific activities were significantly decreased in PAD patients compared to healthy individuals. After treatment with clopidogrel, SOD activities, and SOD specific activities were continuously decrease in PAD patients. The SOD and oxidized protein concentrations were significantly increased in PAD patients compared to healthy individuals. After treatment with clopidogrel, the oxidized protein concentration was significantly decreased, while SOD concentration was significantly increased in PAD patients. These findings suggest that the treatment by clopidogrel stimulated the production of the enzyme but the ratio of active enzyme remained low. The decrease in oxidized protein can be explained by the treatment having antioxidant efficacy that may have compensated for the deficiency in enzyme activity and led to a decrease in oxidized protein. Additionally, the results of this study provide promising evidence that oxidative stress biomarkers including SOD concentration, T-SOD activity, Mn-SOD activity, and oxidized protein levels have potential utility in the diagnosis and management of PAD.
Similar content being viewed by others
REFERENCES
Bhatt, D.L., Eagle, K.A., Ohman, E.M., Hirsch, A.T., Goto, S., Mahoney, E.M., Wilson, P.W.F., Alberts, M.J., D’agostino, R., and Liau, C., Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis, JAMA, 2010, vol. 304, pp. 1350–1357.
Balogh, O., Péntek, M., Gulácsi, L., Farkas, K., Járai, Z., Landi, A., Pécsvárady, Z., and Brodszky, V., Quality of life and burden of disease in peripheral arterial disease: A study among Hungarian patients, Orvosi Hetilap, 2013, vol. 154, no. 12, pp. 464–470. https://doi.org/10.1556/oh.2013.29567
Aboyans, V., Ricco, J., Bartelink, M., Björck, M., Brodmann, M., Cohner, T., Collet, J., Czerny, M., De Carlo, M., Debus, S., et al., 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS), Kardiol. Pol., 2017, vol. 75, no. 11, pp. 1065–1160. https://doi.org/10.5603/kp.2017.0216
Allison, M.A., Ho, E., Denenberg, J.O., Langer, R.D., Newman, A.B., Fabsitz, R.R., and Criqui, M.H., Ethnic-specific prevalence of peripheral arterial disease in the United States, Am. J. Preventive Med., 2007, vol. 32, no. 4, pp. 328–333. https://doi.org/10.1016/j.amepre.2006.12.010
Anand, S.S., Caron, F., Eikelboom, J.W., Bosch, J., Dyal, L., Aboyans, V., Abola, M.T., Branch, K.R.H., Keltai, K., Bhatt, D.L., et al., Major adverse limb events and mortality in patients with peripheral artery disease, J. Am. Coll. Cardiol., 2018, vol. 71, no. 20, pp. 2306–2315. https://doi.org/10.1016/j.jacc.2018.03.008
Sigvant, B., Wiberg-Hedman, K., Bergqvist, D., Rolandsson, O., Andersson, B., Persson, E., and Wahlberg, E., A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences, J. Vasc. Surg., 2007, vol. 45, no. 6, pp. 1185–1191. https://doi.org/10.1016/j.jvs.2007.02.004
Song, P., Rudan, D., Zhu, Ya., Fowkes, F.J.I., Rahimi, K., Fowkes, F.G.R., and Rudan, I., Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis, Lancet Global Health, 2019, vol. 7, no. 8, pp. e1020–e1030. https://doi.org/10.1016/s2214-109x(19)30255-4
Fowkes, F.G.R., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J.O., McDermott, M.M., Norman, P.E., Sampson, U.K.A., Williams, L.J., Mensah, G.A., and Criqui, M.H., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, 2013, vol. 382, no. 9901, pp. 1329–1340. https://doi.org/10.1016/s0140-6736(13)61249-0
Criqui, M.H., Denenberg, J.O., Langer, R.D., and Fronek, A., The epidemiology of peripheral arterial disease: importance of identifying the population at risk, Vasc. Med., 1997, vol. 2, no. 3, pp. 221–226. https://doi.org/10.1177/1358863x9700200310
Abaraogu, U.O., Ezenwankwo, E.F., Dall, P.M., and Seenan, C.A., Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease, PLoS One, 2018, vol. 13, no. 11, p. e0207456. https://doi.org/10.1371/journal.pone.0207456
Dean, L. and Kane, M., Clopidogrel therapy and CYP2C19 genotype, 2018.
Lee, C.R., Luzum, J.A., Sangkuhl, K., Gammal, R.S., Sabatine, M.S., Stein, C.M., Kisor, D.F., Limdi, N.A., Lee, Ye.M., Scott, S.A., et al., Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update, Clin. Pharmacol. Ther., 2022, vol. 112, no. 5, pp. 959–967. https://doi.org/10.1002/cpt.2526
Rao, K.K.K. and Lakshmi, K.R., Design, development, and evaluation of clopidogrel bisulfate floating tablets, Int. J. Pharm. Invest., 2014, vol. 4, no. 1, p. 19. https://doi.org/10.4103/2230-973x.127736
The clopidogrel in unstable angina to prevent recurrent events trial investigators, effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, New Engl. J. Med., 2001, vol. 345, pp. 494–502.
Brouwer, J.M.J.L., Nijenhuis, M., Soree, B., Guchela-ar, H., Swen, J.J., van Schaik, R.H.N., van der Weide, J., Rongen, G.A.P.J.M., Buunk, A., and de Boer-Ve-ger, N.J., Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs, Eur. J. Hum. Genet., 2022, vol. 30, no. 10, pp. 1114–1120. https://doi.org/10.1038/s41431-021-01004-7
Al-Ani, A.W., Adenosine deaminase and guanine deaminase: the potential role in diabetic foot ulcers, Iraqi J. Sci., 2023, pp. 4930–4941. https://doi.org/10.24996/ijs.2023.64.10.4
Al-Hameed, N. M. and Al-Ani, A.W., Assessment of systemic oxidative stress and antioxidants in Iraqi women with newly diagnosed and tamoxifen-treated breast cancer, Eurasian Chem. Commun., 2022. https://doi.org/10.22034/ecc.2023.365482.1538
Abd Al-Hameed, N.M. and Al-Ani, A.W., The role of monoamine oxidase and atherogenic index in newly diagnosed and tamoxifen treated women with breast cancer, J. Med. Chem. Sci., 2023, vol. 6, pp. 645–655.
Al-Ani, A.W. and Fadel, S.S., Arlyesterase activity of paraoxonase-1 enzyme in Iraqi patients with β-thalassemia minor, Ann. Trop. Med. Public Health, 2019, vol. 22, p. S243. https://doi.org/10.36295/asro.2019.220820
Karmakar, A., Das, A.K., Ghosh, N., and Sil, P.C., Superoxide dismutase, in Antioxidants Effects in Health, Elsevier, 2022, pp. 139–166. https://doi.org/10.1016/b978-0-12-819096-8.00027-6
Wang, H. and Ki, J., Molecular identification, differential expression and protective roles of iron/manganese superoxide dismutases in the green algae Closterium ehrenbergii against metal stress, Eur. J. Protistol., 2020, vol. 74, p. 125689. https://doi.org/10.1016/j.ejop.2020.125689
Hasan, H.R. and Al-Ani, A.W., An economical source for peroxidase: maize cobs, Karbala Int. J. Mod. Sci., 2022, vol. 8, no. 2, pp. 112–122. https://doi.org/10.33640/2405-609x.3227
Ali, S.S., Ahsan, H., Zia, M.K., Siddiqui, T., and Khan, F.H., Understanding oxidants and antioxidants: Classical team with new players, J. Food Biochem., 2020, vol. 44, no. 3, p. e13145. https://doi.org/10.1111/jfbc.13145
Hamed, A. and Hasan, A.W.A.-A., Superoxide dismutase activity in breast cancer patients treated with anastrozole, Onkol. Radioter., 2023, vol. 17, pp. 1–10.
Correia, P.R.M., De Oliveira, E., and Oliveira, P.V., Simultaneous determination of manganese and selenium in serum by electrothermal atomic absorption spectrometry, Talanta, 2002, vol. 57, no. 3, pp. 527–535. https://doi.org/10.1016/s0039-9140(02)00069-3
Mesquita, C.S., Oliveira, R., Bento, F., Geraldo, D., Rodrigues, J.V., and Marcos, J.C., Simplified 2,4-dinitrophenylhydrazine spectrophotometric assay for quantification of carbonyls in oxidized proteins, Anal. Biochem., 2014, vol. 458, pp. 69–71. https://doi.org/10.1016/j.ab.2014.04.034
Perry, J.J.P., Shin, D.S., Getzoff, E.D., and Tainer, J.A., The structural biochemistry of the superoxide dismutases, Biochim. Biophys. Acta, Proteins Proteomics, 2010, vol. 1804, no. 2, pp. 245–262. https://doi.org/10.1016/j.bbapap.2009.11.004
Amrita, J., Mahajan, M., Bhanwer, A.J.S., and Mohan, G., Oxidative stress: an effective prognostic tool for an early detection of cardiovascular disease in menopausal women, Biochem. Res. Int., 2016, vol. 2016, p. 6157605. https://doi.org/10.1155/2016/6157605
Comhair, S.A.A., Bhathena, P.R., Dweik, R.A., Kavuru, M., and Erzurum, S.C., Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response, Lancet, 2000, vol. 355, no. 9204, p. 624. https://doi.org/10.1016/s0140-6736(99)04736-4
Li, X., Lin, Yi., Wang, S., Zhou, S., Ju, J., Wang, X., Chen, Ya., and Xia, M., Extracellular superoxide dismutase is associated with left ventricular geometry and heart failure in patients with cardiovascular disease, J. Am. Heart Assoc., 2020, vol. 9, no. 15, p. e016862. https://doi.org/10.1161/jaha.120.016862
Crawford, A., Fassett, R.G., Coombes, J.S., Kunde, D.A., Ahuja, K.D.K., Robertson, I.K., Ball, M.J., and Geraghty, D.P., Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease, Nephrol. Dialysis Transplant., 2011, vol. 26, no. 9, pp. 2806–2813. https://doi.org/10.1093/ndt/gfq828
Ściskalska, M., Ołdakowska, M., Marek, G., and Milnerowicz, H., Changes in the activity and concentration of superoxide dismutase isoenzymes (Cu/Zn SOD, Mn-SOD) in the blood of healthy subjects and patients with acute pancreatitis, Antioxidants, 2020, vol. 9, no. 10, p. 948. https://doi.org/10.3390/antiox9100948
Xia, Z., Guo, Z., Nagareddy, P.R., Yuen, V., Yeung, E., and Mcneill, J.H., Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats, Eur. J. Pharmacol., 2006, vol. 544, nos. 1–3, pp. 118–125. https://doi.org/10.1016/j.ejphar.2006.06.033
Hadi, N.R., Mohammad, B.I., Ajeena, I.M., and Sahib, H.H., Antiatherosclerotic potential of clopidogrel: antioxidant and anti-inflammatory approaches, BioMed Res. Int., 2013, vol. 2013, p. 790263. https://doi.org/10.1155/2013/790263
Heitzer, T., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., Tschentscher, P., Meinertz, T., Böger, R., and Baldus, S., Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease, Arterioscler., Thromb., Vasc. Biol., 2006, vol. 26, no. 7, pp. 1648–1652. https://doi.org/10.1161/01.atv.0000225288.74170.dc
Davignon, J., Jacob, R.F., and Mason, R.P., The antioxidant effects of statins, Coronary Artery Dis., 2004, vol. 15, no. 5, pp. 251–258. https://doi.org/10.1097/01.mca.0000131573.31966.34
Montecucco, F. and Mach, F., Statins, ACE inhibitors and ARBs in cardiovascular disease, Best Pract. Res. Clin. Endocrinol. Metab., 2009, vol. 23, no. 3, pp. 389–400. https://doi.org/10.1016/j.beem.2008.12.003
Coombes, J.S. and Fassett, R.G., Antioxidant therapy in hemodialysis patients: a systematic review, Kidney Int., 2012, vol. 81, no. 3, pp. 233–246. https://doi.org/10.1038/ki.2011.341
Park, S., Pekas, E.J., Headid, R.J., Son, W., Woo-den, T.K., Song, J., Layec, G., Yadav, S.K., Mishra, P.K., and Pipinos, I.I., Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease, Am. J. Physiol.: Heart Circulatory Physiol., 2020, vol. 319, no. 2, pp. H456–H467. https://doi.org/10.1152/ajpheart.00235.2020
ACKNOWLEDGMENTS
The authors are grateful to the University of Baghdad, College of Science for supporting this manuscript.
Funding
This work was supported by ongoing institutional funding. No additional grants to carry out or direct this particular research were obtained.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
This work does not contain any studies involving human and animal subjects. Data analysis was performed from the open-access database Pulse Transit Time PPG Dataset (version 1.1.0) [9]. According to the Pulse Transit Time PPG Dataset data, all studies were conducted in accordance with the principles of biomedical ethics set out in the 1964 Declaration of Helsinki and its subsequent amendments, and all participants provided written informed consent.
CONFLICT OF INTEREST
The authors of this work declare that they have no conflicts of interest.
Additional information
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fakhri, Y.A., Al-Ani, A.W. Superoxide Dismutase and Clopidogrel: A Potential Role in Peripheral Arterial Disease Treatment. Dokl Biochem Biophys (2024). https://doi.org/10.1134/S1607672924600088
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1134/S1607672924600088